Skip to content Skip to footer

Cutaneous Sarcoidosis Clinical Trials

Advancing Hope Through Dermatology Research

Living with Cutaneous Sarcoidosis?

Clinical Trials May Help Explore Potential Treatment Options

Cutaneous sarcoidosis is a rare inflammatory skin condition caused by the formation of granulomas in the skin. It may appear as plaques, papules, nodules, or discolored skin lesions that can affect different parts of the body, particularly the face, arms, and upper body. In some individuals, the condition may also involve other organs such as the lungs or lymph nodes. Although sarcoidosis is considered uncommon, cutaneous manifestations can significantly affect a person’s physical comfort, appearance, emotional well-being, and quality of life. Clinical trials for cutaneous sarcoidosis continue to play an important role in evaluating potential new therapies and improving patient care.

Living with cutaneous sarcoidosis may interfere with daily routines, confidence, social interactions, and overall mental health. Symptoms may persist for years and can vary widely between individuals. Many patients continue to struggle despite currently available therapies, highlighting the need for additional research and improved treatment options. Early diagnosis and proper medical care may help manage symptoms and reduce complications associated with chronic inflammation. Individuals searching for a cutaneous sarcoidosis research study in Michigan may benefit from learning more about ongoing clinical research opportunities.

If you or someone you know has cutaneous sarcoidosis, specialists at Revival Research Institute are conducting Cutaneous Sarcoidosis Clinical Trials to evaluate potential treatment options for adults living with this condition.

Are You Eligible to Participate?

To qualify for the Cutaneous Sarcoidosis Clinical Trials, participants must:

*Additional Criteria may apply.

Participation in the Cutaneous Sarcoidosis Clinical Trials is free of cost. To learn more or enroll, complete the form below. A member of our research team will contact you to discuss your potential eligibility for the study.

This field is for validation purposes and should be left unchanged.
Who is this information for?*(Required)

Please provide YOUR contact information only.

Name(Required)
Best Time to Call(Required)
User Agreement(Required)
This is our Privacy Policy.

Cutaneous Sarcoidosis Clinical Trials Flyer

About Cutaneous Sarcoidosis Clinical Trials

Living with cutaneous sarcoidosis can impact many aspects of everyday life. Persistent skin lesions, irritation, discomfort, fatigue, and emotional stress may interfere with work, relationships, self-esteem, and overall well-being. Some individuals may continue experiencing symptoms despite using currently available medications.

Revival Research Institute is conducting a clinical trial for adults living with active cutaneous sarcoidosis. This study is designed to evaluate the safety and efficacy of an investigational treatment being studied for inflammatory conditions including cutaneous sarcoidosis.

Clinical trials will be conducted at multiple locations across the United States, including Texas. Participants who qualify will complete study visits, medical assessments, laboratory testing, and skin evaluations throughout the study period. Eligible participants may receive investigational treatment or placebo during portions of the study.

To take the next step, complete the form above. A member of our research team will contact you to determine if you qualify. A brief discussion regarding your medical history and symptoms may be required.

*All study-related procedures and study treatments are provided at no cost. No insurance is required to participate.

Get Started: What to Expect?

If you are living with cutaneous sarcoidosis, you may qualify for clinical trials for cutaneous sarcoidosis exploring potential treatment options. After completing the interest form above, a member of our research team will contact you for a brief pre-screening discussion to determine if you meet the initial eligibility requirements.

If you qualify, you will be asked to review and sign an Informed Consent Form (ICF), which explains the study procedures, potential risks, possible benefits, and participant responsibilities. Once consent is provided, you may be invited to one of Revival Research Institute’s study sites for additional screening evaluations. These assessments may include physical examinations, skin evaluations, laboratory testing, vital signs, ECGs, and a review of your medical history. Participants who meet all study requirements may be enrolled in the Cutaneous Sarcoidosis Clinical Trial.

Our research team is committed to helping participants fully understand the study process and what participation may involve. You are encouraged to ask questions before deciding whether participation is right for you. Your involvement may help advance future treatment options for individuals living with cutaneous sarcoidosis.

Age Icon
Age
18 years or older
Condition Icon
Condition
Cutaneous Sarcoidosis
Location Icon
Location
Michigan

Cutaneous Sarcoidosis: A Rare Inflammatory Skin Disorder

Cutaneous sarcoidosis is a chronic inflammatory disease characterized by the formation of granulomas, or clusters of inflammatory cells, within the skin. The condition can present in many different forms, including plaques, papules, nodules, lupus pernio, or discolored lesions that may affect the face, scalp, arms, or torso. In some cases, skin symptoms may occur alongside involvement of other organs such as the lungs or eyes.

Although some individuals experience mild disease, others may develop persistent or progressive symptoms that significantly affect their quality of life. Visible skin lesions may lead to emotional distress, reduced confidence, anxiety, or social withdrawal. Patients may also experience fatigue, itching, pain, or discomfort associated with chronic inflammation. Individuals interested in cutaneous sarcoidosis clinical trials in Michigan may qualify for ongoing research opportunities evaluating investigational therapies.

Cutaneous Sarcoidosis May Be Triggered By

Common Symptoms of Cutaneous Sarcoidosis Include

Frequently Asked Questions

Your Guide to Cutaneous Sarcoidosis

Got questions about cutaneous sarcoidosis? You’re not alone.

We’ve compiled answers to some of the most common questions about the condition, including symptoms, diagnosis, treatment approaches, and clinical trial participation. Still have questions? Contact our team at +1 (248) 721-9539 and we’ll be happy to assist you.

Cutaneous sarcoidosis is a form of sarcoidosis that affects the skin. It occurs when inflammatory granulomas develop in the skin tissue, leading to visible lesions, bumps, plaques, or discoloration. Symptoms and severity may vary widely between individuals.

Diagnosis typically involves a physical examination, review of medical history, skin assessments, and laboratory testing. In many cases, a skin biopsy may be performed to confirm the presence of granulomas and rule out other skin conditions.

No, cutaneous sarcoidosis is not contagious. It cannot spread from one person to another through contact, coughing, or other forms of interaction. Researchers believe the condition is related to abnormal immune system activity rather than infection.

Current treatment options may include topical medications, corticosteroids, immunosuppressive therapies, or other off-label medications depending on symptom severity and organ involvement. Clinical trials are also being conducted to explore investigational therapies for this condition.

There is no cost to participate in our Cutaneous Sarcoidosis Clinical Trials. Study-related procedures and treatments are provided at no charge.